A clinical trial to study the effects of two drugs, Levobupivacaine and Ropivacaine in tonsillar pillar block in patients undergoing tonsillectomy.

Comparative study of perioperative analgesic efficacy of 0.15 percent Levobupivacaine versus 0.25 percent Ropivacaine for tonsillar pillar block in patients undergoing tonsillectomy. A randomized double blinded trial. - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/07/069703

Enrollment

Registered

2024-07-01

Start date

Unknown

Completion date

Unknown

Last updated

2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Bilateral Tonsillar pillar block: Infiltration of the local anesthetic drug into the anterior pillar at the lower pole and mid pole of each tonsil for a duration of 15 month from IHEC a

Eligibility

Inclusion criteria

Inclusion criteria: American society of anesthesiologist patient status (asa-ps) 1 and 2

Exclusion criteria

Exclusion criteria: 1. Patients with signs of acute pharyngeal infections. 2. Patients with fever. 3. Patients with peritonsillar abscess. 4. Patients with bleeding disorders. 5. Patients with drug allergies. 6. Patients who refuse to participate.

Design outcomes

Primary

Measure	Time frame
1. To compare the post-operative analgesic efficacy of Levobupivacaine and Ropivacaine using NRS (numerical rating scale) and analgesic requirement over the first 24 hours.Timepoint: 15 months	—

Secondary

Measure	Time frame
Recording adverse effects, including bleeding, nausea, vomiting & otalgia if any, post operatively.Timepoint: 15 months	—

Countries

India

Contacts

Public ContactDr Antony John Charles S

Mahatma Gandhi Medical College and Research Institute

anjocharlie@gmail.com9600931102

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026